JOSÉ LUIS
CALLEJAS RUBIO
PROFESOR ASOCIADO CIENCIAS SALUD
Francisco José
García Hernández
Publicaciones en las que colabora con Francisco José García Hernández (21)
2022
-
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
npj Genomic Medicine, Vol. 7, Núm. 1
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
2019
-
LAUDES Study: impact of digital ulcers on hand functional limitation, work productivity and daily activities, in systemic sclerosis patients
Rheumatology International, Vol. 39, Núm. 11, pp. 1875-1882
2017
-
An MIF promoter polymorphism is associated with susceptibility to pulmonary arterial hypertension in diffuse cutaneous systemic sclerosis
Journal of Rheumatology, Vol. 44, Núm. 10, pp. 1453-1457
-
Clinical and epidemiological differences between men and women with systemic sclerosis: A study in a Spanish systemic sclerosis cohort and literature review
Clinical and Experimental Rheumatology, Vol. 35, pp. S89-S97
2015
-
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis
Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35
-
Registry of the Spanish network for systemic sclerosis: Survival, prognostic factors, and causes of death
Medicine (United States), Vol. 94, Núm. 43
2014
-
Erratum: Health-related Internet use by lupus patients in southern Spain (Clin Rheumatol DOI: 10.1007/s10067-013-2395-z)
Clinical Rheumatology
-
Health-related Internet use by lupus patients in southern Spain
Clinical Rheumatology, Vol. 33, Núm. 4, pp. 567-573
2012
-
Association between -174 interleukin-6 gene polymorphism and biological response to rituximab in several systemic autoimmune diseases
DNA and Cell Biology, Vol. 31, Núm. 9, pp. 1486-1491
-
Bone mass and vitamin D in patients with systemic sclerosis from two Spanish regions
Clinical and Experimental Rheumatology, Vol. 30, Núm. 6, pp. 905-911
-
Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: Pooled data from European cohorts
Autoimmunity Reviews, Vol. 11, Núm. 5, pp. 357-364
-
Influence of the IL6 gene in susceptibility to systemic sclerosis
Journal of Rheumatology, Vol. 39, Núm. 12, pp. 2294-2302
-
Registry of the Spanish Network for Systemic Sclerosis: Clinical Pattern According to Cutaneous Subsets and Immunological Status
Seminars in Arthritis and Rheumatism, Vol. 41, Núm. 6, pp. 789-800
2011
-
Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population.
Rheumatology (Oxford, England), Vol. 50, Núm. 11, pp. 1976-1981
2009
-
Investigation of TLR5 and TLR7 as candidate genes for susceptibility to systemic lupus erythematosus
Clinical and Experimental Rheumatology
-
Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans
Journal of Clinical Investigation, Vol. 119, Núm. 4, pp. 911-923
-
STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk
Annals of the Rheumatic Diseases, Vol. 68, Núm. 11, pp. 1746-1753
2006
-
Association study of genetic variants of pro-inflammatory chemokine and cytokine genes in systemic lupus erythematosus
BMC Medical Genetics, Vol. 7
-
Experiencia con rituximab en el tratamiento de pacientes con lupus eritematoso sistémico
Reumatologia Clinica, Vol. 2, Núm. 1, pp. 23-30